litlas
ログインアカウント作成

Douglas Yee

1988–2025 年に発表

128
論文数
22,037
被引用数
84
h 指数
120
i10 指数

被引用数

Douglas Yee の年別被引用数1982 年: 被引用 1 件1989 年: 被引用 4 件1990 年: 被引用 18 件1991 年: 被引用 22 件1992 年: 被引用 35 件1993 年: 被引用 34 件1994 年: 被引用 25 件1995 年: 被引用 34 件1996 年: 被引用 28 件1997 年: 被引用 30 件1998 年: 被引用 44 件1999 年: 被引用 54 件2000 年: 被引用 84 件2001 年: 被引用 88 件2002 年: 被引用 103 件2003 年: 被引用 128 件2004 年: 被引用 123 件2005 年: 被引用 132 件2006 年: 被引用 158 件2007 年: 被引用 165 件2008 年: 被引用 199 件2009 年: 被引用 168 件2010 年: 被引用 176 件2011 年: 被引用 234 件2012 年: 被引用 239 件2013 年: 被引用 204 件2014 年: 被引用 196 件2015 年: 被引用 203 件2016 年: 被引用 162 件2017 年: 被引用 223 件2018 年: 被引用 178 件2019 年: 被引用 540 件2020 年: 被引用 638 件2021 年: 被引用 652 件2022 年: 被引用 474 件2023 年: 被引用 427 件2024 年: 被引用 631 件2025 年: 被引用 346 件2026 年: 被引用 6 件1983〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,773 件、この内訳の 30.6%中国: 引用元論文 860 件、この内訳の 9.5%イギリス: 引用元論文 579 件、この内訳の 6.4%イタリア: 引用元論文 438 件、この内訳の 4.8%カナダ: 引用元論文 373 件、この内訳の 4.1%ドイツ: 引用元論文 328 件、この内訳の 3.6%オーストラリア: 引用元論文 287 件、この内訳の 3.2%フランス: 引用元論文 252 件、この内訳の 2.8%日本: 引用元論文 250 件、この内訳の 2.8%スペイン: 引用元論文 245 件、この内訳の 2.7%オランダ: 引用元論文 203 件、この内訳の 2.2%インド: 引用元論文 185 件、この内訳の 2.1%
0%30.6%その他 25.2%

機関

分野

  • Medicine51.4%
  • Biochemistry, Genetics and Molecular Biology39.1%
  • Immunology and Microbiology2.6%
  • Environmental Science1.2%
  • Neuroscience1.1%
  • Materials Science0.8%
  • その他3.8%

トピック

  • Metabolism, Diabetes, and Cancer5.9%
  • Growth Hormone and Insulin-like Growth Factors3.9%
  • Breast Cancer Treatment Studies2.8%
  • Cancer Immunotherapy and Biomarkers2.8%
  • Cancer Risks and Factors2.6%
  • Cancer, Hypoxia, and Metabolism2.5%
  • その他79.5%

共著者

全論文

検索で開く
  1. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

    著者: Rita Nanda, Minetta C. Liu, Christina Yau, Rebecca Shatsky, Lajos Pusztai, Anne M. Wallace, A. Jo Chien, Andres Forero‐Torres, Erin D. Ellis, Heather Han, Amy S. Clark, Kathy S. Albain, Judy C. Boughey, Nora Jaskowiak, Anthony Elias, Claudine Isaacs, Kathleen Kemmer, Teresa Helsten, Melanie Majure, Erica Stringer-Reasor, Catherine Parker, Marie Catherine Lee, Tufia C. Haddad, Ronald Cohen, Smita Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Adam L. Asare, Jeffrey B. Matthews, Scott Berry, Ashish Sanil, Richard B. Schwab, W. Fraser Symmans, Laura van ‘t Veer, Douglas Yee, Angela DeMichele, Nola M. Hylton, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, Donald A. Berry, Laura J. Esserman - JAMA Oncology 2020 被引用: 706

  2. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

    著者: Denise M. Wolf, Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee, Zelos Zhu, Mark Jesus M. Magbanua, Rosalyn W. Sayaman, Nicholas O’Grady, Amrita Basu, Amy L. Delson, Jean Philippe Coppé, Ruixiao Lu, Jerome J. Braun, Smita Asare, Laura Sit, Jeffrey B. Matthews, Jane Perlmutter, Nola M. Hylton, Minetta C. Liu, Paula R. Pohlmann, W. Fraser Symmans, Hope S. Rugo, Claudine Isaacs, Angela DeMichele, Douglas Yee, Donald A. Berry, Lajos Pusztai, Emanuel F. Petricoin, Gillian L. Hirst, Laura J. Esserman, Laura van ‘t Veer - Cancer Cell 2022 被引用: 326

  3. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

    著者: Lajos Pusztai, Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace, Erica String-Reasor, Judy C. Boughey, A. Jo Chien, Anthony Elias, Heather Beckwith, Rita Nanda, Kathy S. Albain, Amy S. Clark, Kathleen Kemmer, Kevin Kalinsky, Claudine Isaacs, Alexandra Thomas, Rebecca Shatsky, Theresa L. Helsten, Andres Forero‐Torres, Minetta C. Liu, Lamorna Brown Swigart, Emmanuel Petricoin, Julia Wulfkuhle, Smita Asare, Amy Wilson, Ruby Singhrao, Laura Sit, Gillian L. Hirst, Scott Berry, Ashish Sanil, Adam L. Asare, Jeffrey B. Matthews, Jane Perlmutter, Michelle Melisko, Hope S. Rugo, Richard B. Schwab, W. Fraser Symmans, Douglas Yee, Laura J. van’t Veer, Nola M. Hylton, Angela DeMichele, Donald A. Berry, Laura J. Esserman - Cancer Cell 2021 被引用: 330

  4. Diabetes and Cancer

    著者: Edward L. Giovannucci, David M. Harlan, Michael C. Archer, Richard M. Bergenstal, Susan M. Gapstur, Laurel A. Habel, Michaël Pollak, Judith G. Regensteiner, Douglas Yee - Diabetes Care 2010 被引用: 2,244

  5. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

    著者: Mark Jesus M. Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Smita Asare, Minetta C. Liu, Kathy S. Albain, A. Jo Chien, Andres Forero‐Torres, Claudine Isaacs, Rita Nanda, Debu Tripathy, Angel Rodriguez, Himanshu Sethi, Alexey Aleshin, Matthew Rabinowitz, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela DeMichele, Hope S. Rugo, Laura van ‘t Veer - Cancer Cell 2023 被引用: 171

  6. Diabetes and Cancer: A Consensus Report

    著者: Edward L. Giovannucci, David M. Harlan, Michael C. Archer, Richard M. Bergenstal, Susan M. Gapstur, Laurel A. Habel, Michaël Pollak, Judith G. Regensteiner, Douglas Yee - CA A Cancer Journal for Clinicians 2010 被引用: 1,062

  7. Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

    著者: Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn-Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Oluwole Fadare, Molly Klein, Stefan E. Pambuccian, Beiyun Chen, Kathi Adamson, Sharon B. Sams, Paulette Mhawech‐Fauceglia, Anthony M. Magliocco, Mike Feldman, Mara H. Rendi, Husain Sattar, Jay Zeck, Idris Tolgay Ocal, Ossama Tawfik, Lauren LeBeau, Sunati Sahoo, Tuyethoa N. Vinh, A. Jo Chien, Andres Forero‐Torres, Erica Stringer-Reasor, Anne M. Wallace, Lajos Pusztai, Judy C. Boughey, Erin D. Ellis, Anthony Elias, Janice Lu, Julie E. Lang, Hyo S. Han, Amy S. Clark, Rita Nanda, Donald W. Northfelt, Qamar J. Khan, Rebecca K. Viscusi, David Euhus, Kirsten K. Edmiston, Jane Yuet Ching Hui, Kathleen Kemmer, John W. Park, Minetta C. Liu, Olufunmilayo I. Olopade, Brian Leyland‐Jones, Debasish Tripathy, Stacy L. Moulder, Hope S. Rugo, Richard B. Schwab, Shelly S. Lo, Teresa Helsten, Heather Beckwith, Patricia Haugen, Nola M. Hylton, Laura J. van’t Veer, Jane Perlmutter, Michelle Melisko, Amy Wilson, Garry Peterson, Adam L. Asare, Meredith Buxton, Melissa Paoloni, Julia L. Clennell, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Jeffrey B. Matthews, Smita Asare, Ashish Sanil, Scott Berry, Laura J. Esserman, Donald A. Berry - JAMA Oncology 2020 被引用: 225

  8. I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer

    著者: Haiyun Wang, Douglas Yee - Current Breast Cancer Reports 2019 被引用: 167

  9. Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    著者: Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, Christina Yau, Laura van ‘t Veer, Meredith Buxton, Michael Hogarth, Nola M. Hylton, Melissa Paoloni, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, A. Jo Chien, Anne M. Wallace, Henry G. Kaplan, Judy C. Boughey, Tufia C. Haddad, Kathy S. Albain, Minetta C. Liu, Claudine Isaacs, Qamar J. Khan, Julie E. Lang, Rebecca K. Viscusi, Lajos Pusztai, Stacy L. Moulder, Jane Yuet Ching Hui, Kathleen Kemmer, Anthony Elias, Kirsten K. Edmiston, David Euhus, Barbara Haley, Rita Nanda, Donald W. Northfelt, Debasish Tripathy, William C. Wood, Cheryl A. Ewing, Richard B. Schwab, Julia Lyandres, Sarah Davis, Gillian L. Hirst, Ashish Sanil, Donald A. Berry, Laura J. Esserman - New England Journal of Medicine 2016 被引用: 555

  10. APOBEC3B is an enzymatic source of mutation in breast cancer

    著者: Michael B. Burns, Lela Lackey, Michael A. Carpenter, Anurag S. Rathore, Allison M. Land, Brandon Leonard, Eric W. Refsland, Delshanee Kotandeniya, Natalia Tretyakova, Jason B. Nikas, Douglas Yee, Nuri A. Temiz, Duncan Donohue, Rebecca M. McDougle, William L. Brown, Emily K. Law, Reuben S. Harris - Nature 2013 被引用: 888

  11. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer

    著者: W. Fraser Symmans, Christina Yau, Yunn-Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Michael D. Feldman, Xiuzhen Duan, Beiyun Chen, Husain Sattar, Laila Khazai, Jay Zeck, Sharon B. Sams, Paulette Mhawech‐Fauceglia, Mara H. Rendi, Sunati Sahoo, Idris Tolgay Ocal, Fang Fan, Lauren LeBeau, Tuyethoa N. Vinh, Megan L. Troxell, A. Jo Chien, Anne M. Wallace, Andres Forero‐Torres, Erin D. Ellis, Kathy S. Albain, Rashmi K. Murthy, Judy C. Boughey, Minetta C. Liu, Barbara Haley, Anthony Elias, Amy S. Clark, Kathleen Kemmer, Claudine Isaacs, Julie E. Lang, Hyo S. Han, Kirsten K. Edmiston, Rebecca K. Viscusi, Donald W. Northfelt, Qamar J. Khan, Brian Leyland‐Jones, Sara J. Venters, Sonal Shad, Jeffrey B. Matthews, Smita Asare, Meredith Buxton, Adam L. Asare, Hope S. Rugo, Richard B. Schwab, Teresa Helsten, Nola M. Hylton, Laura van ‘t Veer, Jane Perlmutter, Angela DeMichele, Douglas Yee, Donald A. Berry, Laura J. Esserman - JAMA Oncology 2021 被引用: 106

  12. Adaptive Randomization of Neratinib in Early Breast Cancer

    著者: John W. Park, Minetta C. Liu, Douglas Yee, Christina Yau, Laura van ‘t Veer, W. Fraser Symmans, Melissa Paoloni, Jane Perlmutter, Nola M. Hylton, Michael Hogarth, Angela DeMichele, Meredith Buxton, A. Jo Chien, Anne M. Wallace, Judy C. Boughey, Tufia C. Haddad, Jane Yuet Ching Hui, Kathleen Kemmer, Henry G. Kaplan, Claudine Isaacs, Rita Nanda, Debasish Tripathy, Kathy S. Albain, Kirsten K. Edmiston, Anthony Elias, Donald W. Northfelt, Lajos Pusztai, Stacy L. Moulder, Julie E. Lang, Rebecca K. Viscusi, David Euhus, Barbara Haley, Qamar J. Khan, William C. Wood, Michelle Melisko, Richard B. Schwab, Teresa Helsten, Julia Lyandres, Sarah Davis, Gillian L. Hirst, Ashish Sanil, Laura J. Esserman, Donald A. Berry - New England Journal of Medicine 2016 被引用: 460

  13. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial

    著者: A. Jo Chien, Debasish Tripathy, Kathy S. Albain, W. Fraser Symmans, Hope S. Rugo, Michelle Melisko, Anne M. Wallace, Richard B. Schwab, Teresa Helsten, Andres Forero‐Torres, Erica Stringer-Reasor, Erin D. Ellis, Henry G. Kaplan, Rita Nanda, Nora Jaskowiak, Rashmi K. Murthy, Constantine Godellas, Judy C. Boughey, Anthony Elias, Barbara Haley, Kathleen Kemmer, Claudine Isaacs, Amy S. Clark, Julie E. Lang, Janice Lu, Larissa A. Korde, Kirsten K. Edmiston, Donald W. Northfelt, Rebecca K. Viscusi, Douglas Yee, Jane Perlmutter, Nola M. Hylton, Laura J. van’t Veer, Angela DeMichele, Amy Wilson, Garry Peterson, Meredith Buxton, Melissa Paoloni, Julia L. Clennell, Scott Berry, Jeffrey B. Matthews, Katherine Steeg, Ruby Singhrao, Gillian L. Hirst, Ashish Sanil, Christina Yau, Smita Asare, Donald A. Berry, Laura J. Esserman - Journal of Clinical Oncology 2020 被引用: 112

  14. Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

    著者: Rebecca Shatsky, Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian, Butch Tsiatis, Anne M. Wallace, A. Jo Chien, Erica Stringer-Reasor, Judy C. Boughey, Coral Omene, Mariya Rozenblit, Kevin Kalinsky, Anthony Elias, Christos Vaklavas, Heather Beckwith, Nicole Williams, Mili Arora, Chaitali Nangia, Evanthia T. Roussos Torres, Brittani Thomas, Kathy S. Albain, Amy S. Clark, Carla I. Falkson, Dawn L. Hershman, Claudine Isaacs, Alexandra Thomas, Jennifer F. Tseng, Amy Sanford, Kay T. Yeung, Sarah G Boles, Yunni Yi Chen, Laura A. Huppert, Nusrat Jahan, Catherine Parker, Karthik V. Giridhar, Frederick M. Howard, Mallory Blackwood, Tara Sanft, Wen Li, Natsuko Onishi, Adam L. Asare, Philip Beineke, Peter Norwood, Lamorna Brown Swigart, Gillian L. Hirst, Jeffrey B. Matthews, Brian A. Moore, W. Fraser Symmans, Elissa R. Price, Diane Heditsian, Barbara LeStage, Jane Perlmutter, Paula R. Pohlmann, Angela DeMichele, Douglas Yee, Laura van ‘t Veer, Nola M. Hylton, Laura J. Esserman - Nature Medicine 2024 被引用: 40

  15. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer

    著者: Emily K. Law, Anieta M. Sieuwerts, Kelly LaPara, Brandon Leonard, Gabriel J. Starrett, Amy M. Molan, Nuri A. Temiz, Rachel I. Vogel, Marion E. Meijer‐van Gelder, Fred C.G.J. Sweep, Paul N. Span, John A. Foekens, John W.M. Martens, Douglas Yee, Reuben S. Harris - Science Advances 2016 被引用: 240

  16. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer

    著者: Michael A. Carpenter, Nuri A. Temiz, Mahmoud A. Ibrahim, Matthew C. Jarvis, Margaret R. Brown, Prokopios P. Argyris, William L. Brown, Gabriel J. Starrett, Douglas Yee, Reuben S. Harris - PLoS Genetics 2023 被引用: 50

  17. Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

    著者: Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura van ‘t Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudine Isaacs, Judy C. Boughey, Kathy S. Albain, Kathleen Kemmer, Barbara Haley, Hyo S. Han, Andres Forero‐Torres, Anthony Elias, Julie E. Lang, Erin D. Ellis, Rachel L. Yung, Debu Tripathy, Rita Nanda, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Teresa Helsten, Erin Roesch, Cheryl A. Ewing, Michael Alvarado, Erin P. Crane, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Smita Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Adam L. Asare, Jeffrey B. Matthews, Scott Berry, Ashish Sanil, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, Richard B. Schwab, W. Fraser Symmans, Nola M. Hylton, Donald A. Berry, Laura J. Esserman, Angela DeMichele - Nature Communications 2021 被引用: 73

  18. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update

    著者: Beverly Moy, R. Bryan Rumble, Steven E. Come, Nancy E. Davidson, Angelo Di Leo, Julie R. Gralow, Gabriel N. Hortobagyi, Douglas Yee, Ian E. Smith, Mariana Chavez-MacGregor, Rita Nanda, Heather L. McArthur, Laura Spring, Katherine E. Reeder-Hayes, Kathryn J. Ruddy, Paul S. Unger, Shaveta Vinayak, William J. Irvin, Avan Armaghani, Michael A. Danso, Natalie Dickson, Sophie S. Turner, Cheryl L. Perkins, Lisa A. Carey - Journal of Clinical Oncology 2021 被引用: 67

  19. Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

    著者: Nathan Ungerleider, Sonia G. Rao, Ashkan Shahbandi, Douglas Yee, Tianhua Niu, Wesley D. Frey, James G. Jackson - Breast Cancer Research 2018 被引用: 105

  20. Quantum Dots for Cancer Diagnosis and Therapy: Biological and Clinical Perspectives

    著者: Hua Zhang, Douglas Yee, Chun Wang - Nanomedicine 2008 被引用: 255

  21. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.

    著者: Kalpna Gupta, Smita Kshirsagar, Liming Chang, Robert A. Schwartz, Ping‐Yee Law, Douglas Yee, Robert P. Hebbel - 2002 被引用: 532

  22. Revisiting the IGF-1R as a breast cancer target

    著者: Roudy Chiminch Ekyalongo, Douglas Yee - npj Precision Oncology 2017 被引用: 115

  23. Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

    著者: Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero‐Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara Haley, Anthony Elias, Judy C. Boughey, Kathleen Kemmer, Rachel L. Yung, Paula R. Pohlmann, Debu Tripathy, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Emanuel F. Petricoin, Erica Stringer-Reasor, Carla I. Falkson, Melanie Majure, Rita A. Mukhtar, Teresa Helsten, Stacy L. Moulder, Patricia A. Robinson, Julia Wulfkuhle, Lamorna Brown Swigart, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Ashish Sanil, Scott Berry, Smita Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Nola M. Hylton, Angela DeMichele, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van’t Veer, Donald A. Berry, Laura J. Esserman - npj Breast Cancer 2021 被引用: 29

  24. IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

    著者: Xin Huang, Haein Park, J.T. Greene, James Pao, Erin Mulvey, Sophia X. Zhou, Catherine M. Albert, Fred Moy, Deepali Sachdev, Douglas Yee, Christoph Rader, Carl V. Hamby, David M. Loeb, Mitchell S. Cairo, Xianzheng Zhou - PLoS ONE 2015 被引用: 108